United States · Venture startup
6 rounds we have observed, with the 7 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$53Mraised across 6 rounds since 2009, from 6 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
From a historical funding recordSEC filing: $7.0M sold, first sale Aug 2015
From a historical funding recordSEC filing: $23M sold, first sale Apr 2014
Reported by finsmes.comSEC filing: $5.8M sold, first sale Feb 2013
Reported by sec.govSEC filing: $7.2M sold, first sale Feb 2012
No investor was named in the report.
Reported by masshightech.comSEC filing: $3.0M sold, first sale Oct 2010
No investor was named in the report.
Reported by masshightech.comSEC filing: $2.0M sold, first sale Dec 2009
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Polaris Partners
Lux Capital
Third Rock Ventures
Crown Venture Fund
AbbVie
Ysios CapitalLighthouse Capital PartnersMissing a round, or an investor who was in one? Tell us.
Kala Pharmaceuticals's investors include Polaris Partners, Lux Capital, Third Rock Ventures, Crown Venture Fund and AbbVie, and 2 more on record.
Kala Pharmaceuticals has raised $53M across 6 rounds since 2009.
Kala Pharmaceuticals's most recent round was a Venture of $7.0M in Aug 2015.
Kala Pharmaceuticals's largest round on record is $23M (Series B), in Apr 2014.
Kala Pharmaceuticals's first round on record, in Mar 2012, was backed by Polaris Partners, Lux Capital and Third Rock Ventures and 1 others.
Kala Pharmaceuticals's latest named round is a Venture, in Aug 2015.
Kala Pharmaceuticals is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States ·